Erschienen in:
07.03.2016 | Short Communication
A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal
verfasst von:
Hajime Iwasaki, Tomoki Sasakawa, Kenichi Takahoko, Shunichi Takagi, Hideki Nakatsuka, Takahiro Suzuki, Hiroshi Iwasaki
Erschienen in:
Journal of Anesthesia
|
Ausgabe 3/2016
Einloggen, um Zugang zu erhalten
Abstract
We report the use of rocuronium to re-establish neuromuscular block after reversal with sugammadex. The aim of this study was to investigate the relationship between the dose of rocuronium needed to re-establish neuromuscular block and the time interval between sugammadex administration and re-administration of rocuronium. Patients who required re-establishment of neuromuscular block within 12 h after the reversal of rocuronium-induced neuromuscular block with sugammadex were included. After inducing general anesthesia and placing the neuromuscular monitor, the protocol to re-establish neuromuscular block was as follows. An initial rocuronium dose of 0.6 mg/kg was followed by additional 0.3 mg/kg doses every 2 min until train-of-four responses were abolished. A total of 11 patients were enrolled in this study. Intervals between sugammadex and second rocuronium were 12–465 min. Total dose of rocuronium needed to re-establish neuromuscular block was 0.6–1.2 mg/kg. 0.6 mg/kg rocuronium re-established neuromuscular block in all patients who received initial sugammadex more than 3 h previously. However, when the interval between sugammadex and second rocuronium was less than 2 h, more than 0.6 mg/kg rocuronium was necessary to re-establish neuromuscular block.